You are here: Industry Insights > Intravacc

News List

Nasal Spray Corona Vaccine Enters Clinical Trial contractpharma
January 05, 2022
Leiden Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine.
Intravacc's Inactivated Polio Vaccine Out-licensed to Sinovac contractpharma
July 21, 2021
Sinovac's Eupolio vaccine (sIPV) receives market authorization from the NMPA in China.
Intravacc Unveils New Pilot Vaccine Production Facility contractpharma
February 20, 2021
Intravacc, a vaccine research and development company, said that its new modern pilot production plant will soon be operational. In addition, the Dutch company is leading a consortium that will start with the concept design (phase I) of ...
Intravacc Completes Project for Provention Bio’s Vax Candidate contractpharma
January 20, 2021
Contract development and manufacturing organization (CDMO) Intravacc, said that a candidate polyvalent inactivated coxsackievirus B (CVB) vaccine it developed and manufactured for Provention Bio in less than 36 months, has entered into a first in ...
Intravacc gets US NIAID contract to develop enterovirus D68 vaccine expresspharma
September 17, 2020
EV D68 is a respiratory virus that can cause childhood paralysis, acute flaccid myelitis.
Collaboration to develop the world’s first prophylactic gonorrhoea vaccine europeanpharmaceuticalreview
August 26, 2020
Therapyx and Intravacc will jointly develop NGoXIM, a microsphere vaccine which is designed to stimulate adaptive immunity against gonorrhoea.
Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine b3cnewswire
August 22, 2020
In the beginning of March this year Intravacc started working on the development of four candidate coronavirus vaccines based on three proprietary technologies: Vero cell, OMV and iBoost.
Intravacc, Celonic to Develop and Produce a Novel COVID-19 Vaccine americanpharmaceuticalreview
August 05, 2020
Intravacc and Celonic have signed a research agreement to further design, develop and produce a Covid-19 vaccine based on an immunogenic Spike (S) protein of SARS-CoV-2 combined with Intravacc’s prorietary Outer Membrane Vesicle (OMV) technology.
Intravacc and Celonic team up to develop Covid-19 vaccine pharmaceutical-technology
July 31, 2020
Intravacc has partnered with contract development and manufacturing organisation (CDMO) Celonic Group for the design, development and production of a Covid-19 vaccine.
Animal replacement method for vaccine testing developed by Intravacc and Leiden University expresspharma
July 27, 2020
As a result of the Covid-19 pandemic, some 400 therapies and vaccines against this virus are currently being developed worldwide. This affects the number of laboratory animals used in studies.

Previous page 1 2 Next page